Theriva Biologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.16

+0.01 (+4.35%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +23,970.9% upside

Low Target $26.34

Average Target $38.73

High Target $46.19

Current Price $0.16

Current
$0.16

Target
$38.73

$26.34 $38.73 avg $46.19

Scenario Analysis

Bear Case

$26.34

16,270.4%

Low target

Base Case

$38.73

+23,970.9%

Avg target

Bull Case

$46.19

+28,607.3%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$0.49

-67.3% from high

52-Week Low

$0.14

+18.3% from low

Target vs 52W High

$38.73

+7,772.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%